Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzymotec Ltd (NASDAQ:ENZY)

9.10
Delayed Data
As of 4:00pm ET
 +0.10 / +1.11%
Today’s Change
5.20
Today|||52-Week Range
9.32
+38.93%
Year-to-Date
No recent news for Enzymotec Ltd.

Today’s Trading

Previous close9.00
Today’s open9.00
Day’s range9.00 - 9.10
Volume12,973
Average volume (3 months)40,238
Market cap$204.9M
Dividend yield--
Data as of 4:00pm ET, 02/22/2017

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-52.78%
Earnings growth (next 5 years)+13.28%
Revenue growth (last year)+6.98%
P/E ratio--
Price/Sales4.53
Price/Book1.50

Competitors

 Today’s
change
Today’s
% change
OSIROsiris Therapeutics ...-0.40-6.81%
CYADCelyad SA+0.62+2.98%
AUPHAurinia Pharmaceutic...-0.28-7.61%
IMGNImmunoGen Inc0.000.00%
Data as of 4:00pm ET, 02/22/2017

Financials

Last reporting dateFebruary 22, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$50.4M
Annual profit (last year)$6.7M
Net profit margin13.26%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Ariel Katz
Chief Financial Officer &
Vice President
Oren Bryan
Corporate headquarters
Migdal HaEmeq, Hazafon

Forecasts


Search for Jobs